Now available IMAAVY™

IMAAVY™ (nipocalimab-aahu) injection, for intravenous use, is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients 12 years of age and older who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.

View full prescribing information.